Neurological Sciences

, Volume 36, Issue 4, pp 553–560 | Cite as

Anti-amnesic activity of Citrus aurantium flowers extract against scopolamine-induced memory impairments in rats

  • Samira Rahnama
  • Zahra Rabiei
  • Zahra Alibabaei
  • Shiva Mokhtari
  • Mahmoud Rafieian-kopaei
  • Fatemeh Deris
Original Article


Alzheimer’s disease (AD) is a progressive neurological disorder that mostly affects the elderly population. Learning and memory impairment as the most characteristic manifestation of dementia could be induced chemically by scopolamine, a cholinergic antagonist. Cholinergic neurotransmission mediated brain oxidative stress. Citrus aurantium (CA) has traditionally been used for the treatment of insomnia, anxiety and epilepsy. The present study was designed to investigate the effect of Citrus aurantium on scopolamine-induced learning and memory deficit in rats. Forty-two Wistar rats were divided into six equal groups. (1) Control (received saline), (2) SCOP (scopolamine at a dose of 1 mg/kg for 15 days), (3) and (4) SCOP + CA (scopolamine and CA extract at doses of 300 and 600 mg/kg per day for 15 days), (5) and (6) intact groups (CA extract at 300 and 600 mg/kg per day for 15 days, respectively). Administration of CA flower extract significantly restored memory and learning impairments induced by scopolamine in the passive avoidance test and also reduced escape latency during trial sessions in the Morris water maze test. Citrus aurantium flower extract significantly decreased the serum malondialdehyde (MDA) levels. Citrus aurantium flower extract has repairing effects on memory and behavioral disorders produced by scopolamine and may have beneficial effects in the treatment of AD.


Citrus aurantium Memory impairment Scopolamine Alzheimer’s disease MDA Shuttlebox 



This study was conducted with the assistance of Medical Plants Research Center of Shahrekord University of Medical Science and was approved by the Ethics Committee of Shahrekord University of Medical Sciences. Authors also would like to thank Research and Technology Deputy of Shahrekord University of Medical Sciences for their financial support.


  1. 1.
    Parihar MS, Hemnani T (2004) Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neurosci 11(5):456–467CrossRefPubMedGoogle Scholar
  2. 2.
    Nie K, Yu J-C, Fu Y, Cheng H-Y, Chen F-Y, Qu Y et al (2009) Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem Biophys Res 378(1):103–107CrossRefGoogle Scholar
  3. 3.
    Small G, Bullock R (2011) Defining optimal treatment with cholinesterase inhibitors in Alzheimer’s disease. Alzheimers Dement 7(2):177–184CrossRefPubMedGoogle Scholar
  4. 4.
    Rezvani AH, Cauley M, Sexton H, Xiao Y, Brown ML, Paige MA et al (2011) Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. Psychopharmacology 215(4):621–630CrossRefPubMedGoogle Scholar
  5. 5.
    Hashimoto M, Hashimoto T, Kuriyama K (1991) Protective effect of WEB 1881 FU on AF64A (ethylcholine aziridinium ion)-induced impairment of hippocampal cholinergic neurons and learning acquisition. Eur J Pharmacol 209(1):9–14CrossRefPubMedGoogle Scholar
  6. 6.
    Kvaltinova Z, Juranek I, Machova J, Stolc S (1993) Effect of oxidative stress on (3H) N-methylscopolamine binding and production of thiobarbituric acid reactive substances in rat cerebral cortex membranes. Gen Physiol Biophys 12:155–164PubMedGoogle Scholar
  7. 7.
    Vasco VRL (2012) Phosphoinositide pathway and the signal transduction network in neural development. J Neurosci Res 28(6):789–800Google Scholar
  8. 8.
    Floyd RA, Hensley K (2002) Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23(5):795–807CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang Z-J (2004) Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75(14):1659–1699CrossRefPubMedGoogle Scholar
  10. 10.
    Akhlaghi M, Shabanian G, Rafieian-Kopaei M, Parvin N, Saadat M, Akhlaghi M (2011) Citrus aurantium blossom and preoperative anxiety. Rev Bras Anestesiol 61(6):702–712CrossRefPubMedGoogle Scholar
  11. 11.
    Pereira R, Andrades N, Paulino N, Sawaya A, Eberlin M, Marcucci M et al (2011) Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules 12(7):1352–1366CrossRefGoogle Scholar
  12. 12.
    Tundis R, Loizzo MR, Bonesi M, Menichini F, Mastellone V, Colica C et al (2012) Comparative study on the antioxidant capacity and cholinesterase inhibitory activity of Citrus aurantifolia swingle, C. aurantium L., and C. bergamia Risso and Poit. Peel essential oils. J Food Sci 77(1):40–46CrossRefGoogle Scholar
  13. 13.
    Jazayeri B, Amanlou A, Ghanadian N, Pasalar P, Amanlou M (2014) A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine. DARU J PharmSci 22:17CrossRefGoogle Scholar
  14. 14.
    Rabiei Z, Rafieian-kopaei M, Heidarian E, Saghaei E, Mokhtari S (2013) Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus basalis of meynert in rat. Neurochem Res 36:1–8Google Scholar
  15. 15.
    Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47–60CrossRefPubMedGoogle Scholar
  16. 16.
    Ellman GL, Courtney KD, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharm 7(2):88–95CrossRefPubMedGoogle Scholar
  17. 17.
    Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S (2005) Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res 2(3):307–318CrossRefPubMedGoogle Scholar
  18. 18.
    Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T (2004) Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 78:787–791CrossRefPubMedGoogle Scholar
  19. 19.
    Lorenzini CA, Baldi E, Bucherelli C, Sacchetti B, Tassoni G (1996) Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat’s passive avoidance response: a tetrodotoxin functional inactivation study. Brain Res 730(1–2):32–39CrossRefPubMedGoogle Scholar
  20. 20.
    Nakajima A, Yamakuni T, Matsuzaki K, Nakata N, Onozuka H, Yokosuka A et al (2007) Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling. J Pharm Exp Ther 321(2):784–790CrossRefGoogle Scholar
  21. 21.
    Pereira R, Andrades N, Paulino N, Sawaya A, Eberlin M, Marcucci M et al (2007) Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules 12(7):1352–1366CrossRefPubMedGoogle Scholar
  22. 22.
    Carvalho-Freitas MIR, Costa M (2002) Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol Pharm Bull 25(12):1629–1633CrossRefPubMedGoogle Scholar
  23. 23.
    Vazquez J, Baghdoyan HA (2003) Muscarinic and GABAA receptors modulate acetylcholine release in feline basal forebrain. Eur J Neurosci 17:249–259CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  • Samira Rahnama
    • 1
  • Zahra Rabiei
    • 1
  • Zahra Alibabaei
    • 1
  • Shiva Mokhtari
    • 1
  • Mahmoud Rafieian-kopaei
    • 1
  • Fatemeh Deris
    • 2
  1. 1.Medical Plants Research CenterShahrekord University of Medical SciencesShahrekordIran
  2. 2.Department of Biostatistics and Epidemiology, Health FacultyShahrekord University of Medical SciencesShahrekordIran

Personalised recommendations